207 related articles for article (PubMed ID: 28665480)
21. Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Kaminski H; Jarque M; Halfon M; Taton B; Di Ascia L; Pfirmann P; Visentin J; Garrigue I; Déchanet-Merville J; Moreau JF; Crespo E; Montero N; Melilli E; Meneghini M; Pascual M; Couzi L; Manuel O; Bestard O; Merville P
J Infect Dis; 2019 Jul; 220(5):761-771. PubMed ID: 31157865
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of valganciclovir in the treatment of cytomegalovirus disease in kidney and pancreas transplant recipients.
Luan FL; Chopra P; Park J; Norman S; Cibrik D; Ojo A
Transplant Proc; 2006 Dec; 38(10):3673-5. PubMed ID: 17175363
[TBL] [Abstract][Full Text] [Related]
23. The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
Transplantation; 2015 Mar; 99(3):602-8. PubMed ID: 25148381
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
[TBL] [Abstract][Full Text] [Related]
25. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
Tarasewicz A; Dębska-Ślizień A; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1650-3. PubMed ID: 27496465
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of cytomegalovirus infection after pancreas transplantation.
Parsaik AK; Bhalla T; Dong M; Rostambeigi N; Dierkhising RA; Dean P; Abraham R; Prieto M; Kremers WK; Razonable RR; Kudva YC
Transplantation; 2011 Nov; 92(9):1044-50. PubMed ID: 21904269
[TBL] [Abstract][Full Text] [Related]
27. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis.
Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S
Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
31. Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomes.
Zona E; Jorgenson M; Dolma S; Santos A; Garg N; Aziz F; Mohamed M; Saddler CM; Smith JA; Mandelbrot D; Parajuli S
Clin Transplant; 2023 Jun; 37(6):e14979. PubMed ID: 36967240
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus Status of Kidney Transplant Recipients and Cardiovascular Risk.
Komorowska-Jagielska K; Heleniak Z; Dębska-Ślizień A
Transplant Proc; 2018; 50(6):1868-1873. PubMed ID: 30056918
[TBL] [Abstract][Full Text] [Related]
33. BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study.
Blazquez-Navarro A; Dang-Heine C; Wittenbrink N; Bauer C; Wolk K; Sabat R; Westhoff TH; Sawitzki B; Reinke P; Thomusch O; Hugo C; Or-Guil M; Babel N
EBioMedicine; 2018 Aug; 34():113-121. PubMed ID: 30072213
[TBL] [Abstract][Full Text] [Related]
34. Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.
Magua W; Johnson AC; Karadkhele GM; Badell IR; Vasanth P; Mehta AK; Easley KA; Newell KA; Rickert JB; Larsen CP
Transpl Infect Dis; 2022 Dec; 24(6):e13983. PubMed ID: 36321801
[TBL] [Abstract][Full Text] [Related]
35. Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.
Toyoda M; Shin BH; Ge S; Mirocha J; Thomas D; Chu M; Rodriguez E; Chao C; Petrosyan A; Galera OA; Vo A; Choi J; Peng A; Kahwaji J; Jordan SC
J Immunol Res; 2017; 2017():5672523. PubMed ID: 28265581
[TBL] [Abstract][Full Text] [Related]
36. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
[TBL] [Abstract][Full Text] [Related]
37. Valganciclovir administration to kidney donors to reduce the burden of cytomegalovirus and Epstein-Barr virus transmission during transplantation.
Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
Transplantation; 2015 Jun; 99(6):1186-91. PubMed ID: 25489844
[TBL] [Abstract][Full Text] [Related]
38. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients.
Nafar M; Roshan A; Pour-Reza-Gholi F; Samadian F; Ahmadpoor P; Samavat S; Abbasi MA
Iran J Kidney Dis; 2014 May; 8(3):231-5. PubMed ID: 24878947
[TBL] [Abstract][Full Text] [Related]
40. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
